期刊文献+

儿童脓毒症及严重脓毒症患儿血液sCD163变化及其意义 被引量:6

Changes and significance of soluble CD 163 in sepsis and severe sepsis in children
原文传递
导出
摘要 目的探讨脓毒症及严重脓毒症患儿血液可溶性CD163(sCD163)水平,评估其在病情严重程度及脓毒症免疫状态判断中的价值。方法前瞻性实验,采用双抗体夹心ELISA方法,测定入住本院儿童重症医学科(PICU)50例脓毒症/严重脓毒症患儿血清sCD163含量,同期选择23例健康检查儿童作为对照;分析sCD163与病情严重程度评分(pediatriccriticalillnessscore.PCIS:pediatricriskofmortalitym,PRISMm)、淋巴细胞亚群、C反应蛋白(CRP)、肿瘤坏死因子d(TNFc~)之间的关系。研究方案经医院伦理委员会批准,签转家长知情同意书。结果实验组患儿与健康组儿童血清sCD163分别为(171.04±177.85)mg/L和(44.19±86.48)mg/L,差异有统计学意义(P〈0.01)。脓毒症与严重脓毒症患儿sCD163分别为(105.32-4-145.87)mg/L和(233.32±171.78)mg/L.差异有统计学意义(P〈0.05)。PCIS分值≥90、70-89及〈70患儿中,PCIS分值越低,sCD163水平越高,三组差异有统计学意义(P〈0.01)。PRISMHI≥10组血清sCD163浓度明显高于PRISMⅢ〈10组(P〈0.01)。死亡组sCD163水平高于生存组,差异有统计学意义。sCD163与CD4+、CIM+/CD8+呈负相关(R=-0.820,P〈0.05,R=-0.839,P〈0.叭)。结论血清sCD163测定有助于预测脓毒症患儿病情严重程度,是脓毒症患儿免疫状态判断参考指标之一。 Objective To investigate the changes of serum soluble CD 163 ( sCD 163 ) level, to assess the severity of critical illness and to evaluate the immune status of sepsis or severe sepsis in children. Method A prospective study was conducted. The sCD 163 was determined in 50 cases with sepsis or severe sepsis in pediatric intensive care unit (PICU) and 23 cases of age- and gender-matched healthy children were enrolled as control during the period from April 2010 to March 2011. Double-antibody sandwich ELISA was used for sCD 163 measurement. The relationship with sCD 163 level and disease severity score ( pediatric critical illness score, PCIS; and pediatric risk of mortalityⅢ, PRISMⅢ), lymphocyte subsets, C-reactive protein (CRP), tumor necrosis factor α (TNFa) were analyzed. Result The sCD 163 in sepsis/severe sepsis groups ( 171.04± 177. 85) mg/L was significantly higher than that in control group (44. 19 ±86.48) mg/L (P 〈0. 01 ). sCD 163 in sepsis group [ ( 105.32 ± 145.87) mg/L] was significantly lower than that of severe sepsis group [ (233.32 ± 171.78 ) mg/L] ( P 〈 0. 05 ). sCD 163 level was significantly higher in lower PCIS score patients. (P 〈0. 01 ). The sCD 163 levels was higher in PRISMⅢ≥10 than the PRISM Ⅲ 〈 10 group. The sCD 163 levels were higher in death group than the survival group. The sCD 163 was negatively correlated with CD4 + , CD4 + /CD8 + (R = - 0. 820,P 〈0. 05;R = -0. 839, P 〈0.01 ). Conclusion Detection of sCD 163 was helpful in predicting the severity of sepsis and severe sepsis, and sCD 163 may reflect the immune status of critically ill children with sepsis.
出处 《中华儿科杂志》 CAS CSCD 北大核心 2012年第9期653-656,共4页 Chinese Journal of Pediatrics
关键词 脓毒症 危重病 全身炎症综合征 儿童 可溶性CD 163 Sepsis Critical illness Systemic inflammatory response syndrome Child Soluble CD 163
  • 相关文献

参考文献12

  • 1Osuehowski MF, Welch K, Siddiqui J, et al. CJr:ulating cytokine/inhibitor profiles reshape the understanding of the SIRS/ CARS continuum in sepsis and predict mortality. Immunol, 2006, 177 : 1967-1974.
  • 2Fabriek BO, van Bruggen R, Deng DM, et al. The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria. Blood, 2009, l 13:887-892.
  • 3Groselj-Grenc M, Ihan A, Derganc M. Neutrophil and monocyte CD64 and CD163 expression in critically ill neonates and chihtren with sepsis: comparison of fluorescence intensities and calculated indexes. Mediato Inflamm,2008, 2008:202646.
  • 4Goldstein B, Giroir B, Randolph A, et al. International pediatrie sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med, 2005,6:2-8.
  • 5Davis BH, Zarev PV. Human monocyte CDI63 expression inversely correlates with soluble CD163 plasma levels. Cytometry B Clin Cytom,2005, 63 : 16-22.
  • 6Cam,1 ED, Mankhambo LA, Jeffers G, et al. The diagnostic and prognostic accuracy of five markers of serious bacterial infection in Malawian children with signs of severe infection. PLoS One, 2009, 4 :e6621.
  • 7Gafni S, Pedersen SS, Koldkaer OG, et al. New immunological serum markers in baeteraemia: anti-inflammatory soluble CD163, but nol proinflammatory high mobility group-box 1 protein, is related to prognosis. Clin Exp hnmunol, 2008, 151:423431.
  • 8Mgller HJ, Moestrup SK, Weis N, et al. Macrophage serum markers in pneumoeoceal bacteremia: prediction of survival by soluble CD163. Critical Care Medicine, 2006, 34:2561-2566.
  • 9Reddy RC, Chen GH, Tekchandani PK, et a|. Sepsis induced immuno-suppression: fi'om bad to worse. Immuol RES, 2001,24: 273 -287.
  • 10Hotehkiss RS, Karl 1E. The pathophysiology and treatment of sepsis. N Engl .I Med,2003, 348 : 138-150.

同被引文献56

引证文献6

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部